Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00573521 · ClinicalTrials.gov registry record
Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 450
- Enrollment target
NCT00573521 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 450 participants.
The verdict
NCT00573521 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
Study Summary
This research will be conducted to determine whether risk factors exist for piperacillin/tazobactam resistance in ESBL organisms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2007-11 |
| Est. Completion | 2017-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00573521
The ClinicalTrials.gov registry entry for NCT00573521 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00573521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00573521 about?
NCT00573521 is a clinical study titled "Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms". This research will be conducted to determine whether risk factors exist for piperacillin/tazobactam resistance in ESBL organisms.
What is the current status of trial NCT00573521?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2007-11. Estimated completion is 2017-06.
Who is sponsoring clinical trial NCT00573521?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.